No Data
No Data
No Data
No Data
No Data
Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024
Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") will host an earnings call to announce its first quarter 2024 financial results and provide an operational update for the Company on Wednesday, May 1, 2024, before the market opens.
BusinesswireApr 24 16:30 ET
Summit Therapeutics Appoints Biotech Veteran to Board
TipRanksApr 11 16:52 ET
Express News | Summit Therapeutics Appoints DR. Mostafa Ronaghi, Renowned Executive and Genomicist, to Its Board of Directors
Moomoo 24/7Apr 11 16:30 ET
Summit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned Executive and Genomicist, to Its Board of Directors
Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that Mostafa Ronaghi, PhD, has been appointed to its Board of Directors, effective immediately.
BusinesswireApr 11 16:30 ET
Analysts Offer Insights on Healthcare Companies: Avita Medical (RCEL), Summit Therapeutics (SMMT) and Neurocrine (NBIX)
TipRanksApr 11 07:30 ET
Summit Therapeutics to Present at the Stifel 2024 Targeted Oncology Forum
Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that it will participate in and present at the Stifel 2024 Targeted Oncology Forum, which will be held virtually April 16-17, 2024. Dr. Maky Zanganeh, Chief Executive Officer and President, Robert W. Duggan, Chairman and Chief Executive Officer, Manmeet Soni, Chief Operating Officer & Chief Financial Officer, Dave Gancarz, Chief Business & Strategy Officer, and Dr. Allen S. Yang, Chief Medical Officer, will participate in a fireside chat on behalf of our organization surrounding the development of our innovative investigational bispecific antibody, ivonescimab, on Tuesday April 16, 2024 at 2:30pm ET.
BusinesswireApr 10 07:00 ET
SlowndEasyWins : GRabed few here
TrytosaveabitOP SlowndEasyWins: I think it will end up being a decent swing! GL
SlowndEasyWins TrytosaveabitOP: It’s not real swing trade sell at resistance longer hold type small bet only I don’t like swing trade below 5$ valuation anyway
TrytosaveabitOP SlowndEasyWins: I consider anything longer than a day, a swing! Whether I’m looking for bottom to buy and hold for data/PR/deal! And could hold for 6/8+ weeks! Others swings are severely OS ATL/Near ATL/52WKL with a chart that’s saying reversal coming!
SlowndEasyWins TrytosaveabitOP: Great insight thanks !
No Data
No Data
JESSE JAMES8832 : i see there whole pipeline consists of different variantes of iovnescinab
888huat888 : Crashing soon